Distinct cellular and genetic differences in colorectal cancer in young patients

Researchers from the Dana-Farber Cancer Institute, Mass General Brigham, and the Broad Institute have conducted the largest study to date on colorectal cancer in young patients, finding distinct cellular and genetic differences in the disease. The study, published in Nature Medicine, aims to understand why colorectal cancer is more aggressive in younger people and to develop future treatments. The researchers found that younger patients are more likely to be diagnosed at advanced stages and that the disease is the leading cause of cancer death in people under 50. The study lays a foundation for further investigation into the biology of early-onset disease and the development of novel strategies for prevention, diagnosis, and treatment. The researchers hope to discover new ways to prevent and treat colorectal cancer in young patients, who are often diagnosed during their most formative years of life. The study's findings could have important implications for the development of targeted therapies and improved patient outcomes.